Koninklijke Philips Retained Earnings (Accumulated Deficit) 2010-2025 | PHG
- Koninklijke Philips retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $3.927B, a 54.15% decline year-over-year.
- Koninklijke Philips retained earnings (accumulated deficit) for 2024 were $3.95B, a 32.44% decline from 2023.
- Koninklijke Philips retained earnings (accumulated deficit) for 2023 were $5.847B, a 18.78% decline from 2022.
- Koninklijke Philips retained earnings (accumulated deficit) for 2022 were $7.198B, a 34.89% decline from 2021.
Koninklijke Philips Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
---|---|
2024 | $3,950 |
2023 | $5,847 |
2022 | $7,198 |
2021 | $11,055 |
2020 | $8,942 |
2019 | $9,292 |
2018 | $9,762 |
2017 | $9,716 |
2016 | $9,111 |
2015 | $8,928 |
2014 | $11,685 |
2013 | $13,834 |
2012 | $13,778 |
2011 | $17,991 |
2010 | $20,587 |
2009 | $22,240 |
Koninklijke Philips Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
---|---|
2025-03-31 | $3,927 |
2024-06-30 | $4,019 |
2023-06-30 | $5,831 |
2023-03-31 | |
2022-06-30 | $8,566 |
2021-06-30 | $8,764 |
2020-06-30 | $7,392 |
2019-06-30 | |
2018-06-30 | $9,535 |
2017-06-30 | $9,153 |
2016-12-31 | $9,111 |
2016-09-30 | $9,058 |
2016-06-30 | $8,806 |
2016-03-31 | $8,816 |
2015-12-31 | $8,928 |
2015-09-30 | $9,524 |
2015-06-30 | $9,121 |
2015-03-31 | $9,834 |
2014-12-31 | $11,685 |
2014-09-30 | $12,675 |
2014-06-30 | $13,308 |
2014-03-31 | $14,111 |
2013-12-31 | $13,834 |
2013-09-30 | $13,122 |
2013-06-30 | $13,619 |
2013-03-31 | $14,334 |
2012-12-31 | $13,778 |
2012-09-30 | $14,181 |
2012-06-30 | $16,011 |
2012-03-31 | $17,174 |
2011-12-31 | $17,991 |
2011-09-30 | $19,146 |
2011-06-30 | $19,419 |
2011-03-31 | $20,293 |
2010-12-31 | $20,587 |
2010-09-30 | $21,041 |
2010-06-30 | $20,122 |
2010-03-31 | $21,507 |
2009-12-31 | $22,240 |
2009-09-30 | $21,204 |
2009-06-30 | $19,961 |
2009-03-31 | $21,467 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $23.476B | $19.503B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
Boston Scientific (BSX) | United States | $152.664B | 38.22 |
Stryker (SYK) | United States | $149.191B | 31.19 |
EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
Medtronic (MDT) | Ireland | $115.147B | 16.32 |
Lonza Group Ag (LZAGY) | Switzerland | $50.094B | 0.00 |
Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
ResMed (RMD) | United States | $37.280B | 28.00 |
GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
Agilent Technologies (A) | United States | $32.221B | 21.01 |
Terumo (TRUMY) | Japan | $24.355B | 31.64 |
Insulet (PODD) | United States | $20.287B | 79.63 |
Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
Baxter (BAX) | United States | $14.559B | 10.87 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
Haemonetics (HAE) | United States | $3.575B | 16.28 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.342B | 27.77 |
ICU Medical (ICUI) | United States | $3.072B | 22.66 |
LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
AtriCure (ATRC) | United States | $1.504B | 0.00 |
Acuren (TIC) | United States | $1.431B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
Neogen (NEOG) | United States | $1.068B | 13.67 |
BioLife Solutions (BLFS) | United States | $1.006B | 0.00 |
InMode (INMD) | Israel | $0.901B | 9.08 |
Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
Owens & Minor (OMI) | United States | $0.613B | 5.08 |
Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
Evolus (EOLS) | United States | $0.593B | 0.00 |
CeriBell (CBLL) | United States | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Surmodics (SRDX) | United States | $0.446B | 0.00 |
SNDL (SNDL) | Canada | $0.392B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.331B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
Quanterix (QTRX) | United States | $0.283B | 0.00 |
Cerus (CERS) | United States | $0.270B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
ZimVie (ZIMV) | United States | $0.243B | 11.04 |
OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
Brainsway (BWAY) | Israel | $0.230B | 60.75 |
Biote (BTMD) | United States | $0.224B | 6.31 |
Omeros (OMER) | United States | $0.206B | 0.00 |
Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
High Tide (HITI) | Canada | $0.197B | 0.00 |
Organigram Global (OGI) | Canada | $0.196B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.100B | 12.87 |
MacroGenics (MGNX) | United States | $0.096B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.088B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
Apyx Medical (APYX) | United States | $0.079B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
Zynex (ZYXI) | United States | $0.069B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.068B | 0.00 | |
Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
ImmuCell (ICCC) | United States | $0.058B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 14.76 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
Safety Shot (SHOT) | United States | $0.037B | 0.00 |
Nephros (NEPH) | United States | $0.037B | 49.29 |
Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.011B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |